France's Adocia Completes 2012's First Euro Biotech IPO

French drug delivery company, Adocia, raises $33 million to develop new formulations of therapeutic proteins for wound healing, diabetes

In the first biopharma IPO in Europe this year, the French drug delivery company Adocia SAS has raised €25 million ($32.7 million) on NYSE Euronext Paris, in an offering that was oversubscribed.

The listing comes over nine months since Europe’s last biopharma IPO, that of dermatology-focused Moberg Pharma AB in May...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from France

More from Europe